Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics. 1976

Z Haider, and S Obaidullah, and Fayyaz-ud-Din

The clinical effectiveness of glibenclamide and chlorpropamide was compared in 107, uncomplicated, newly diagnosed maturity onset diabetics. The glibenclamide and chlorpropamide groups comprised of 49 and 58 patients respectively and were highly comparable. After a follow up period ranging from 6 months to 2-1/2 years, the failure rate in glibenclamide treated patients was 22.5% and 12% in those taking chlorpropamide. The changes in weight were similar and both drugs were devoid of serious toxic effects in the dosage prescribed. Symptoms of hypoglycaemia were seen in 2 patients on glibenclamide, while 3 patients in each group showed a modest rise of transaminases without any other evidence of liver damage.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420

Related Publications

Z Haider, and S Obaidullah, and Fayyaz-ud-Din
February 1975, Lancet (London, England),
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
December 1970, Postgraduate medical journal,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
December 1970, Postgraduate medical journal,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
December 1970, Postgraduate medical journal,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
September 1978, Diabete & metabolisme,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
May 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
August 1977, Diabetologia,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
February 1972, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Z Haider, and S Obaidullah, and Fayyaz-ud-Din
December 1977, British medical journal,
Copied contents to your clipboard!